MedKoo Cat#: 577437 | Name: Miproxifene phosphate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Miproxifene phosphate is a biochemical that was studied for antiestrogen therapy for breast cancer patients.

Chemical Structure

Miproxifene phosphate
Miproxifene phosphate
CAS#115767-74-3

Theoretical Analysis

MedKoo Cat#: 577437

Name: Miproxifene phosphate

CAS#: 115767-74-3

Chemical Formula: C29H36NO5P

Exact Mass: 509.2331

Molecular Weight: 509.58

Elemental Analysis: C, 68.35; H, 7.12; N, 2.75; O, 15.70; P, 6.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Miproxifene phosphate; TAT-59; TAT 59; TAT59
IUPAC/Chemical Name
Phenol, 4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-(4-(1-methylethyl)phenyl)-1-butenyl)-, dihydrogen phosphate (ester), (E)-
InChi Key
QZUHFMXJZOUZFI-ZQHSETAFSA-N
InChi Code
InChI=1S/C29H36NO5P/c1-6-28(23-9-7-22(8-10-23)21(2)3)29(25-13-17-27(18-14-25)35-36(31,32)33)24-11-15-26(16-12-24)34-20-19-30(4)5/h7-18,21H,6,19-20H2,1-5H3,(H2,31,32,33)/b29-28+
SMILES Code
CC\C(=C(\c1ccc(OCCN(C)C)cc1)/c2ccc(OP(=O)(O)O)cc2)\c3ccc(cc3)C(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 509.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Shibata J, Toko T, Saito H, Lykkesfeldt AE, Fujioka A, Sato K, Hashimoto A, Wierzba K, Yamada Y. Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59). Cancer Chemother Pharmacol. 2000;45(2):133-41. doi: 10.1007/s002800050021. Erratum in: Cancer Chemother Pharmacol 2000;46(2):172. PMID: 10663628. 2. Morimoto K, Abe O, Kinoshita H. [Steady state and disappearance of the metabolites of miproxifene phosphate in the treatment of breast cancer]. Gan To Kagaku Ryoho. 1998 Aug;25(10):1565-73. Japanese. PMID: 9725050. 3. Toko T, Saito H, Fujioka A, Nukatuka M, Sato K, Hashimoto A, Shibata J, Yamada Y. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma]. Gan To Kagaku Ryoho. 1998 May;25(6):829-38. Japanese. PMID: 9617321.